» » »

Blood Flow Mismatch in Pancreatic Cancers Durham NC

Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness. The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people.

Douglas Rivera, MD
Durham, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Nishan Hesiri Fernando, MD
(919) 681-5257
Box 3477 Duke Univ Medical Ctr,
Durham, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Duke Univ Sch Of Med, Durham Nc 27710
Graduation Year: 1997

Data Provided by:
Sharon Freedman
(919) 684-8111
2100 Erwin Rd
Durham, NC
Specialty
Hematology

Data Provided by:
Sherri Arthur Zimmerman, MD
(919) 677-8402
PO Box 2916,
Durham, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med, Chapel Hill Nc 27599
Graduation Year: 1991

Data Provided by:
Corinne Linardic
(919) 620-4467
2100 Erwin Rd
Durham, NC
Specialty
Hematology / Oncology

Data Provided by:
Andrew Berchuck, MD
(919) 684-3765
PO Box 3079,
Durham, NC
Specialties
Oncology (Cancer), Gynecological Oncology
Gender
Male
Education
Medical School: Case Western Reserve Univ Sch Of Med, Cleveland Oh 44106
Graduation Year: 1980

Data Provided by:
Sascha A Tuchman
(919) 684-8111
2100 Erwin Rd
Durham, NC
Specialty
Hematology

Data Provided by:
Amy Pickar Abernethy, MD
(919) 668-0647
Box 3436,
Durham, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Duke Univ Sch Of Med, Durham Nc 27710
Graduation Year: 1994

Data Provided by:
Randall Paul Scheri
(919) 684-8111
2100 Erwin Rd
Durham, NC
Specialty
General Surgery, Surgical Oncology

Data Provided by:
Susan Gail Kreissman, MD
(919) 668-1729
Ped Hematol/oncol Box 2916 Duke Medicine Center,
Durham, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Mt Sinai Sch Of Med Of The City Univ Of Ny, New York Ny 10029
Graduation Year: 1985

Data Provided by:
Data Provided by:

Blood Flow Mismatch in Pancreatic Cancers

Provided By:

WEDNESDAY, Aug. 26 (HealthDay News) -- Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness.

The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people. The researchers noted that blood flow in malignant tumors was 60 percent less than in normal pancreatic tissue.

The findings may help explain why many pancreatic cancer patients have a poor response to radiation treatment and chemotherapy, the study authors noted in their report published Aug. 25 in Clinical Cancer Research.

"Imaging of several of these tumor parameters might be important for the planning and success of [cancer] therapies," study author Dr. Gaber Komar, research fellow at the Turku PET Center, said in a news release from the American Association for Cancer Research. "We believe that a better understanding of these mechanisms may help overcome the general treatment resistance of pancreatic cancer."

"This study confirms that blood flow metabolism mismatch exists in pancreatic tumors, similar to other cancers such as breast and lung cancers, and predicts poor patient outcome," Dr. David Mankoff, a professor of radiology, medicine and bioengineering at the University of Washington in Seattle, said in the news release.

"A blood flow metabolism mismatch by PET appears to be associated with cancer aggressiveness and treatment resistance. We've only recently recognized this pattern as a result of advantages in functional imaging methods," added Mankoff.

More information

The American Cancer Society has more about pancreatic cancer.

SOURCE: American Association for Cancer Research, news release, Aug. 25, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com